Curaleaf Holdings, Inc. (OTCMKTS:CURLF – Get Free Report)’s share price was down 5.4% during mid-day trading on Friday. The stock traded as low as $9.5950 and last traded at $9.73. Approximately 101,440 shares changed hands during mid-day trading, a decline of 65% from the average daily volume of 293,445 shares. The stock had previously closed at $10.2832.
Analyst Upgrades and Downgrades
Several analysts have weighed in on CURLF shares. Zacks Research raised Curaleaf from a “hold” rating to a “strong-buy” rating in a report on Tuesday, July 14th. Citigroup reaffirmed a “buy” rating on shares of Curaleaf in a research note on Thursday, August 6th. Three research analysts have rated the stock with a Strong Buy rating and two have given a Buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Strong Buy”.
Read Our Latest Analysis on CURLF
Curaleaf Stock Performance
Curaleaf (OTCMKTS:CURLF – Get Free Report) last posted its earnings results on Wednesday, August 5th. The company reported $0.05 earnings per share for the quarter, topping the consensus estimate of ($0.20) by $0.25. Curaleaf had a negative return on equity of 0.88% and a negative net margin of 2.62%.The firm had revenue of $340.10 million for the quarter, compared to analyst estimates of $332.00 million. On average, research analysts predict that Curaleaf Holdings, Inc. will post 0.01 earnings per share for the current year.
About Curaleaf
Curaleaf Holdings, Inc is a cannabis company that cultivates, processes, manufactures and sells cannabis products. Through its retail dispensaries and wholesale operations, the company offers flower, pre-rolls, vaporizers, edibles, concentrates, tinctures and other cannabis-derived products for medical and adult-use markets, where permitted by law.
Curaleaf markets products under brands that include Curaleaf, Select and Grassroots. Its business is primarily focused on the United States, where it operates a network of cultivation and processing facilities, dispensaries and distribution operations across multiple state-regulated cannabis markets.
Recommended Stories
- Five stocks we like better than Curaleaf
- AST SpaceMobile’s BlueBird Progress Comes With Several Risks Still Unresolved
- Time to Nibble on MCD Stock After it Enters Oversold Territory?
- McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal Upside
- Corning and AT&T’s $3 Billion Fiber Deal Reveals Where AI Spending Goes Next
Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.
